Vimarsana
Biggest News Aggregation in the World

Page 8 - Script Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Script Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Script Biotech Today - Breaking & Trending Today

Neuroscience Antibodies and Assays Market 2023-2027 Along with 5-Year Historic (2017-2021) Industry Size & Comparison of 20 Vendors and 12 Countries - Vimarsana News

Neuroscience Antibodies and Assays Market 2023-2027 Along with 5-Year Historic (2017-2021) Industry Size & Comparison of 20 Vendors and 12 Countries

/PRNewswire/ -- The Neuroscience Antibodies and Assays Market share is expected to increase by USD 1837.68 million from 2022 to 2027, with an accelerated CAGR...

Neuroscience Antibodies and Assays Market 2023-2027 Along with 5-Year Historic (2017-2021) Industry Size & Comparison of 20 Vendors and 12 Countries - Vimarsana News

Neuroscience Antibodies and Assays Market 2023-2027 Along with 5-Year Historic (2017-2021) Industry Size & Comparison of 20 Vendors and 12 Countries

/PRNewswire/ -- The Neuroscience Antibodies and Assays Market share is expected to increase by USD 1837.68 million from 2022 to 2027, with an accelerated CAGR...

GenScript Supported Nasal Spray Development for COVID-19 Protection with GMP-grade Antibodies and Subsequently Planned for Long-Term Collaboration with Biogenexis - Vimarsana News

GenScript Supported Nasal Spray Development for COVID-19 Protection with GMP-grade Antibodies and Subsequently Planned for Long-Term Collaboration with Biogenexis

SINGAPORE, Nov. 1, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supported Chulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production and characterization services. The antibodies were licensed to Hibiocy Co. Ltd., which further developed them into a nasal spray medical device named VAILL COVITRAP. The Thai FDA has approved VAILL COVITRAP as a Class 4 medical device, making Thailand the first country to approve the manufact...

Gene Synthesis Services Market to Record a CAGR of 17.6%, Majority of Market Growth to Originate from North America - Vimarsana News

Gene Synthesis Services Market to Record a CAGR of 17.6%, Majority of Market Growth to Originate from North America

/PRNewswire/ -- The gene synthesis services market will be dominated by North America during the forecast period. The region will account for 38% of the...

Gene Synthesis Services Market to Record a CAGR of 17.6%, Majority of Market Growth to Originate from North America - Vimarsana News

Gene Synthesis Services Market to Record a CAGR of 17.6%, Majority of Market Growth to Originate from North America

/PRNewswire/ -- The gene synthesis services market will be dominated by North America during the forecast period. The region will account for 38% of the...